CrushSCI.com
154.1Average days
139Median days
44Fastest days
361Longest days
762025 publications

Paper Review Records

All Paper Review Records

22 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

95 days

Stage‐Associated Collagen Gene Expression and Macrophage‐Associated Immune Features in Nail Unit Melanoma

Authors
Yuri Sawada; Marco A. De Velasco; Megumi Aoki; Kazuko Sakai; Naoki Shiraishi; Kazuyasu Fujii; Shigeto Matsushita; Kazuto Nishio; Atsushi OtsukaShow moreShow less
Affiliations
1. Department of Dermatology Kindai University Faculty of Medicine Sakai Osaka Japan; 2. Department of Genome Biology Kindai University Faculty of Medicine Sakai Osaka Japan; 3. Department of Dermato‐Oncology NHO Kagoshima Medical Center Kagoshima City Kagoshima Japan; 4. Center for Genomics, Life Science Research Institute Kindai University Sakai Osaka Japan; 5. Genome Medical Center, Kindai University Hospital Sakai Osaka JapanShow moreShow less
Source PDF DOI Publisher page
144 days

Development of a Genetically Characterized Panel of 15 Mucosal Melanoma Cell Lines for the Preclinical Evaluation of Targeted Therapies in Human and Veterinary Medicine

Authors
Caroline Confais; Armel Houël; Louis‐Marie Guignard; Jérome Abadie; Stéphane Dréano; Rémy Le Guevel; Rémy Pedeux; Aline Primot; Christophe Drieu La Rochelle; Catherine André; Ulrich Jarry; Benoit HédanShow moreShow less
Affiliations
1. Univ Rennes, CNRS IGDR (Institut de génétique et développement de Rennes) – UMR 6290 Rennes France; 2. Biotrial Pharmacology Unité de Pharmacologie Préclinique Rennes France; 3. LabOniris, Oniris VetAgroBio Nantes France; 4. Univ Rennes, CNRS, INSERM BIOSIT UAR 3480, US_S 018, Impaccell Rennes France; 5. Univ Rennes, INSERM OSS (Oncogenesis Stress Signaling), UMR_S 1242, CLCC Eugene Marquis Rennes France; 6. Univ Rennes, CNRS, INSERM BIOSIT UAR 3480, US_S 018, Oncotrial Rennes FranceShow moreShow less
Source PDF DOI Publisher page
192 days

Preclinical Models of Uveal Melanoma: Strengths, Limitations, and Translational Utility

Authors
Yunxi Chen; Mohamed Abdouh; Julia V. BurnierShow moreShow less
Affiliations
1. Cancer Research Program Research Institute of the McGill University Health Centre Montreal Quebec Canada; 2. Department of Pathology McGill University Montreal Quebec Canada; 3. Gerald Bronfman Department of Oncology McGill University Montreal Quebec CanadaShow moreShow less
Source PDF DOI Publisher page
143 days

Nanopore Sequencing Identifies a Distinct Tyr:: CreER T2 Allele Circulating in Existing Mouse Stocks

Authors
Leah Pomfret; Aro Nugawela; Emma L. Wilkinson; Barbara Shih; Richard L. MortShow moreShow less
Affiliations
1. Division of Biomedical and Life Sciences, Faculty of Health and Medicine Lancaster University Lancaster UKShow moreShow less
Source PDF DOI Publisher page
304 days

Females Display Greater Disease Severity in a Mouse Model of Vitiligo

Authors
Kaitlyn G. O'Donnell; Zhussipbek Mukhatayev; Hanin Abuzer; Rohan S. Shivde; Sriram Saravanan Shanmugavelandy; Octavio K. Bartos; Ellis Kang; Emilia R. Dellacecca; Dinesh Jaishankar; Surya Pandey; Hee Kap Kang; Ziyou Ren; I. Caroline Le PooleShow moreShow less
Affiliations
1. Indiana University School of Medicine Indianapolis Indiana USA; 2. Department of Dermatology, Microbiology and Immunology, Feinberg School of Medicine Northwestern University Chicago Illinois USA; 3. Mayo Clinic College of Medicine and Science, Mayo Clinic Rochester Minnesota USA; 4. Department of Surgery, Feinberg School of Medicine Northwestern University Chicago Illinois USA; 5. Department of Hematology and Oncology, Feinberg School of Medicine Northwestern University Chicago Illinois USA; 6. Department of Pediatrics, Lurie Children's Hospital Northwestern University Chicago Illinois USAShow moreShow less
Source PDF DOI Publisher page
200 days

Mutations in Chromatin Regulator Genes Associate With TMB and Immunotherapy Response in Melanoma

Authors
Marija Gjorgjievska; Djansel Bukovec; Andzelka Ilieva; Milan Risteski; Ivan Kungulovski; Zan Mitrev; Aimilios Lallas; Goran KungulovskiShow moreShow less
Affiliations
1. Zan Mitrev Clinic Skopje Republic of Macedonia; 2. Faculty of Medical Sciences Goce Delcev University Stip North Macedonia; 3. Fingerprint Diagnostics LLC Skopje Republic of Macedonia; 4. Aristotle University of Thessaloniki Thessaloniki GreeceShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Pigment Cell & Melanoma Research take to review a manuscript?

As of 2026-11-18, CrushSCI has 22 complete review records for Pigment Cell & Melanoma Research. The fastest paper went from submission to acceptance in 44 days (Histopathological Analysis Revealed Melanosome‐Retaining Fibroblasts and Autophagy‐Impaired Macrophages in Ashy Dermatosis, received 2026-05-13, accepted 2026-06-26); the slowest took 361 days. The average is 154.1 days and the median is 139 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.